Ledger.Open graph →
SEC Form D · Amendment · filed August 17, 2016

Tioma Therapeutics, Inc

Offering
$86.3M
Sold
$33.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRISBANE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John T. Mckearn · BRISBANE, CADirectorCarole L. Nuechterlein · BRISBANE, CADirectorPamela T. Manning · SAINT LOUIS, MOExecRobert W. Karr · SAINT LOUIS, MOExecJill Carroll · BRISBANE, CADirectorPeter T. Moldt · BRISBANE, CADirectorJohn T. Donovan · BRISBANE, CAExec · DirectorJames L. Stutz · BRISBANE, CAExecJohn T. Mckearn · BRISBANE, CADirectorJohn T. Donovan · BRISBANE, CAExec · DirectorJames L. Stutz · BRISBANE, CAExecCarole L. Nuechterlein · BRISBANE, CADirectorPamela T. Manning · SAINT LOUIS, MOExecRobert W. Karr · CORALVILLE, IAExecJill Carroll · BRISBANE, CADirectorPeter T. Moldt · BRISBANE, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗